• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受肺栓塞治疗患者的死亡率。

Mortality in patients treated for pulmonary embolism.

作者信息

Alpert J S, Smith R, Carlson J, Ockene I S, Dexter L, Dalen J E

出版信息

JAMA. 1976 Sep 27;236(13):1477-80.

PMID:989113
Abstract

The hospital course of 144 consecutive patients with pulmonary embolism (PE) demonstrated by pulmonary angiography was reviewed to determine the mortality of patients with treated PE. Twelve patients (8%) died of PE, and eight died of causes other than PE; 124 (86%) survived. Pulmonary embolism was the primary cause of death in only four of the 12 patients who died of PE. Pulmonary embolism contributed to the death of eight other patients, each of whom had associated potentially lethal disease, particularly heart disease. The most important factor affecting mortality was shock due to acute right ventricular failure secondary to massive PE (mortality, 32%). Mortality was not related to magnitude of PE per se; the mortality of patients with massive PE without shock (6%) was the same as that for patients with submassive PE (5%. Patients with PE who survive long enough to have the diagnosis established and appropriate prophylactic therapy begun have an excellent prognosis, unless they have associated severe medical disease.

摘要

回顾了连续144例经肺血管造影证实患有肺栓塞(PE)患者的住院病程,以确定接受治疗的PE患者的死亡率。12例患者(8%)死于PE,8例死于PE以外的原因;124例(86%)存活。在死于PE的12例患者中,仅4例的主要死因是肺栓塞。肺栓塞导致另外8例患者死亡,这些患者均伴有潜在的致命性疾病,尤其是心脏病。影响死亡率的最重要因素是大面积PE继发急性右心室衰竭所致的休克(死亡率为32%)。死亡率与PE本身的严重程度无关;无休克的大面积PE患者的死亡率(6%)与次大面积PE患者的死亡率(5%)相同。存活时间足够长以确诊并开始适当预防性治疗的PE患者预后良好,除非他们伴有严重的内科疾病。

相似文献

1
Mortality in patients treated for pulmonary embolism.接受肺栓塞治疗患者的死亡率。
JAMA. 1976 Sep 27;236(13):1477-80.
2
Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism.大面积和次大面积急性肺栓塞患者的血栓溶解切除术
Catheter Cardiovasc Interv. 2009 Mar 1;73(4):506-13. doi: 10.1002/ccd.21858.
3
AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study.血管内射流血栓切除术治疗高危肺栓塞合并心源性休克患者:一项可行性初步研究。
EuroIntervention. 2013 Apr 22;8(12):1419-27. doi: 10.4244/EIJV8I12A215.
4
[Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].[原发性肺动脉高压或肺栓塞所致急性循环衰竭]
Rev Mal Respir. 2000 Feb;17(1):51-65.
5
Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism.肺栓塞情况下急性右心室衰竭的机械循环支持
J Interv Cardiol. 2018 Aug;31(4):518-524. doi: 10.1111/joic.12503. Epub 2018 Mar 7.
6
[Therapeutic dilemmas in patients with a centrally-located pulmonary embolism confirmed by spiral CT-scan but with no cardiogenic shock].[经螺旋CT扫描确诊为中心型肺栓塞但无心源性休克患者的治疗困境]
Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1400-5.
7
Modified Bova score for risk stratification and short-term outcome in acute pulmonary embolism.改良博瓦评分用于急性肺栓塞的风险分层及短期预后评估
Neth J Med. 2015 Nov;73(9):410-6.
8
Long-term mortality after massive, submassive, and low-risk pulmonary embolism.大面积、次大面积和低危肺栓塞患者的长期死亡率。
Vasc Med. 2020 Apr;25(2):141-149. doi: 10.1177/1358863X19886374. Epub 2019 Dec 17.
9
Thrombolysis is not warranted in submassive pulmonary embolism: a systematic review and meta-analysis.对于次大面积肺栓塞,溶栓治疗并无必要:一项系统评价与荟萃分析
Crit Care Resusc. 2007 Dec;9(4):357-63.
10
High dose and short-term streptokinase infusion in patients with pulmonary embolism: prospective with seven-year follow-up trial.高剂量短期链激酶输注治疗肺栓塞患者:七年随访前瞻性试验
J Thromb Thrombolysis. 2001 Dec;12(3):237-47. doi: 10.1023/a:1015227125177.

引用本文的文献

1
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis.小儿肺栓塞的导管定向治疗:系统评价与荟萃分析
Thromb J. 2025 Jan 17;23(1):4. doi: 10.1186/s12959-024-00674-9.
2
Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism.重症继发性肺栓塞患者死亡率风险预测评分的有效性。
Biomol Biomed. 2024 Feb 28;24(4):990-997. doi: 10.17305/bb.2024.10202.
3
Venous Thromboembolism in Necrotizing Pancreatitis: an Underappreciated Risk.坏死性胰腺炎中的静脉血栓栓塞:一个被低估的风险。
J Gastrointest Surg. 2019 Dec;23(12):2430-2438. doi: 10.1007/s11605-019-04124-0. Epub 2019 Feb 7.
4
Right ventricular (RV) echocardiographic parameters in patients with pulmonary thromboembolism (PTE).肺血栓栓塞症(PTE)患者的右心室(RV)超声心动图参数
ARYA Atheroscler. 2018 Mar;14(2):78-84. doi: 10.22122/arya.v14i2.1494.
5
Double Bolus Alteplase Therapy during Cardiopulmonary Resuscitation for Cardiac Arrest due to Massive Pulmonary Embolism Guided by Focused Bedside Echocardiography.在床旁聚焦超声心动图引导下,对因大面积肺栓塞导致心脏骤停的患者进行心肺复苏时采用双倍剂量阿替普酶治疗。
Case Rep Crit Care. 2018 Mar 19;2018:7986087. doi: 10.1155/2018/7986087. eCollection 2018.
6
The autopsy and diagnosis of pulmonary thrombo-embolism.肺血栓栓塞症的尸检与诊断
Forensic Sci Med Pathol. 2018 Jun;14(2):241-243. doi: 10.1007/s12024-018-9950-5. Epub 2018 Feb 5.
7
Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?肺栓塞患者的初始抗凝治疗:溶栓、普通肝素、低分子肝素、磺达肝癸钠还是 DOACs?
Br J Clin Pharmacol. 2017 Nov;83(11):2356-2366. doi: 10.1111/bcp.13340. Epub 2017 Jul 9.
8
Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.急性肺栓塞中右心室功能障碍评估标志物的选择:N末端脑钠肽前体、肺动脉收缩压、平均动脉压还是血压指数。
Herz. 2017 Dec;42(8):758-765. doi: 10.1007/s00059-016-4513-6. Epub 2016 Dec 13.
9
Interobserver reliability of echocardiography for prognostication of normotensive patients with pulmonary embolism.超声心动图对血压正常的肺栓塞患者预后评估的观察者间可靠性
Cardiovasc Ultrasound. 2014 Aug 4;12:29. doi: 10.1186/1476-7120-12-29.
10
Efficacy and safety of tenecteplase in pulmonary embolism.替奈普酶治疗肺栓塞的疗效与安全性。
J Thromb Thrombolysis. 2014 Jul;38(1):24-9. doi: 10.1007/s11239-013-0985-x.